Large-scale testing (Phase 3)WithdrawnNCT01815723What this trial is testingEfficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Forward-Pharma GmbH
Large-scale testing (Phase 3)Study completedNCT04728360What this trial is testingComparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Bio-Thera Solutions 556
Testing effectiveness (Phase 2)Study completedNCT00687362What this trial is testingEvaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)Who this might be right forPsoriasis Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT03757013What this trial is testingAssess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in FranceWho this might be right forPsoriasis Amgen 453
Testing effectiveness (Phase 2)Study completedNCT01831466What this trial is testingTofacitinib Ointment For Chronic Plaque PsoriasisWho this might be right forPsoriasis VulgarisPsoriasis Pfizer 476
Early research (Phase 1)Study completedNCT01510951What this trial is testingSafety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With PsoriasisWho this might be right forPsoriasis Amgen 9
Testing effectiveness (Phase 2)Study completedNCT05364554What this trial is testingA Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Janssen Research & Development, LLC 227
Large-scale testing (Phase 3)Study completedNCT00687401What this trial is testingEvaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)Who this might be right forPsoriasis Merck Sharp & Dohme LLC 215
Testing effectiveness (Phase 2)Ended earlyNCT05655299What this trial is testingVTX958 Versus Placebo for the Treatment of Moderate to Severe PsoriasisWho this might be right forPsoriasis Ventyx Biosciences, Inc 222
Testing effectiveness (Phase 2)Study completedNCT01107457What this trial is testingA Study in Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 142
Large-scale testing (Phase 3)Study completedNCT03897075What this trial is testingEfficacy and Safety Study of Tildrakizumab in the Treatment of Nail PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Nail Psoriasis Sun Pharmaceutical Industries Limited 99
Testing effectiveness (Phase 2)Study completedNCT01987843What this trial is testingDose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Tanabe Pharma Corporation 142
Large-scale testing (Phase 3)Study completedNCT00658788What this trial is testingSafety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque PsoriasisWho this might be right forPsoriasis Galderma R&D 305
Testing effectiveness (Phase 2)Study completedNCT01894373What this trial is testingAutologous Cytokine Induced Killer Cells (CIK) for Patients With Severe PsoriasisWho this might be right forPsoriasisAdoptive Immunotherapy Chinese PLA General Hospital 10
Not applicableStudy completedNCT03236870What this trial is testingEvaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in ChinaWho this might be right forPsoriasis AbbVie 181
Testing effectiveness (Phase 2)Study completedNCT01096862What this trial is testingExplore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Astellas Pharma Inc 124
Testing effectiveness (Phase 2)Study completedNCT01855880What this trial is testingPhase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis PatientsWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbGenomics B.V Taiwan Branch 54
Testing effectiveness (Phase 2)Study completedNCT01072383What this trial is testingSafety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Vulgaris Biotest 49
Large-scale testing (Phase 3)Study completedNCT03766685What this trial is testingEvaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)Who this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 172
Post-approval studies (Phase 4)Study completedNCT00249808What this trial is testingEfalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic TherapiesWho this might be right forPsoriasis Merck KGaA, Darmstadt, Germany 1,266